45750 Federal Register / Vol. 86, No. 155 / Monday, August 16, 2021 / Notices 

to: Food, water, appropriate hiking 

footwear, and sunscreen. There are no 

restrooms available. 

Agenda items for the September 24, 

2021, session include a recap and 

discussion of the previous day’s field 

tour; an update from the Designated 

Federal Official; discussion of the 

Bridge Creek Area Allotment 

Management Plan and Environmental 

Impact Statement; information sharing 

about the Alvord Allotment 

Management Plan Environmental 

Assessment; and, an opportunity for 

Subcommittee members to share 

information from their constituents and 

present research. Any other matters that 

may reasonably come before the 

Subcommittee may also be included. 

A public comment period is available 

on September 24 at 11:45 a.m. 

Depending on the number of people 

wishing to comment and the time 

available, the amount of time for oral 

comments may be limited. Sessions may 

end early if all business items are 

accomplished ahead of schedule or may 

be extended if discussions warrant more 

time. All meetings, including field tour 

sessions, are open to the public in their 

entirety. 

Public Disclosure of Comments: 

Before including your address, phone 

number, email address, or other 

personal identifying information in your 

comments, please be aware that your 

entire comment—including your 

personal identifying information—may 

be made publicly available at any time. 

While you can ask us in your comment 

to withhold your personal identifying 

information from public review, we 

cannot guarantee that we will be able to 

do so. 

(Authority: 43 CFR 1784.4–2) 

Jeffrey Rose, 

District Manager. 

[FR Doc. 2021–17508 Filed 8–13–21; 8:45 am] 

BILLING CODE 4310–33–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Cooperative Research 

Group on HEDGE V 

Notice is hereby given that, on June 

22, 2021, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Cooperative 

Research Group on HEDGE V (‘‘HEDGE 

V’’) has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing (1) the identities 

of the parties to the venture and (2) the 

nature and objectives of the venture. 

The notifications were filed for the 

purpose of invoking the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. 

Pursuant to Section 6(b) of the Act, 

the identities of the parties to the 

venture are: Cummins, Inc., Columbus, 

IN; Convergent Science, Madison, WI; 

GM Global Technology Operations, LLC 

(GMGTO), Detroit, MI; Volkswagen 

Aktiengesellschaft, Wolfsburg, 

GERMANY; and Robert Bosch LLC, 

Farmington Hills, MI. The general area 

of HEDGE V’s planned activity is to 

identify ICE technologies to achieve 

50% brake thermal efficiency while 

maintaining a stoichiometric air/fuel 

ratio suitable for three-way catalyst 

operation. Other topics of interest to the 

consortium include: large-bore s.i. 

combustion systems; assisted prechambers; Hybrid-ICE focus including 

ICE design for hybrid application; 

engine geometry changes; advanced 

combustion modes, SACI & D–EGR, 

sCO2 as a cooling medium or WHR 

system; high-power and voltage systems 

including microwave enhanced heating, 

CO2 Separation Membrane for Octaneon-Demand, and on-board hydrogen 

generation for combustion 

enhancement. 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2021–17509 Filed 8–13–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to The National 

Cooperative Research and Production 

Act of 1993—Medical CBRN Defense 

Consortium 

Notice is hereby given that, on July 1, 

2021, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Medical CBRN 

Defense Consortium (‘‘MCDC’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

changes in its membership. The 

notifications were filed for the purpose 

of extending the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. Specifically, 

American Type Culture Collection, 

Manassas, VA; Bugworks Research, Inc., 

Fremont, CA; and Indiana University, 

Bloomington, IN; Jubilant HollisterStier, 

Spokane, WA; Lumen Bioscience, Inc., 

Seattle, WA; MBio Diagnostics, Inc. dba 

LightDeck Diagnostics, Boulder, CO; 

UES, Inc., Dayton, OH; Vaxess 

Technologies, Inc., Cambridge, MA; 

Vector RX LLC, Elkridge, MD and 

VitriVax, Inc., Boulder, CO have been 

added as parties to this venture. 

Also, Kestrel Corporation, 

Albuquerque, NM, has withdrawn as a 

party to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and MCDC 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On November 13, 2015, MCDC filed 

its original notification pursuant to 

Section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to Section 

6(b) of the Act on January 6, 2016 (81 

FR 513). 

The last notification was filed with 

the Department on March 29, 2021. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on April 20, 2021 (86 FR 20521). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2021–17504 Filed 8–13–21; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Pistoia Alliance, Inc. 

Notice is hereby given that, on June 

23, 2021, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 

Section 4301 et seq. (the ‘‘Act’’), Pistoia 

Alliance, Inc. filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Scitara Corporation, 

Marlboro, MA; QunaSys, Bunkyo ̄, 

JAPAN; Procter & Gamble, Mason, OH; 

PHEMI Systems Corp., Vancouver, 

CANADA; Orbis Labsystems Services, 

Leopardstown, IRELAND; Nutanix, 


lotter on DSK11XQN23PROD with NOTICES1